Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cassian Yee

Showing results (41-50 of 143) with videos related to

Pageof 15
Sort By:
Small (Weinheim an Der Bergstrasse, Germany)|June 6, 2008
A multimodal targeting nanoparticle for selectively labeling T cellsJonathan Gunn, Herschel Wallen, Omid Veiseh, et al.
Cellular Immunology|May 19, 2018
Early Env-specific CTLs effectively suppress viral replication in SHIV controller macaquesJin Fan, Hua Liang, Tao Shen, et al.
Frontiers in Immunology|January 19, 2026
IL-7: a potential next-generation adjuvant for immune cell therapiesRichard S Hotchkiss, John F DiPersio, Cassian Yee, et al.
Cancer Research|March 1, 2005
Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptorJeffrey J Roszkowski, Gretchen E Lyons, W Martin Kast, et al.
Journal for Immunotherapy of Cancer|October 6, 2020
Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximabJamie S Lin, Daniel Y Wang, Omar Mamlouk, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2005
Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cellsVeronika Groh, Yongqing Q Li, Daniel Cioca, et al.
Research Square|December 23, 2024
BH3 Mimetics Augment Cytotoxic T Cell Killing of Acute Myeloid Leukemia via Mitochondrial Apoptotic MechanismCassian Yee, Kapil Saxena, Esther Ryu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2010
NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune diseaseNobuyoshi Hanaoka, Bana Jabri, Zhenpeng Dai, et al.
Biorxiv : the Preprint Server for Biology|July 27, 2021
Immunogenic SARS-CoV2 Epitopes Defined by Mass SpectrometryKe Pan, Yulun Chiu, Eric Huang, et al.
Nature Communications|May 23, 2019
CTL-mediated immunotherapy can suppress SHIV rebound in ART-free macaquesJin Fan, Hua Liang, Xiaolin Ji, et al.
Pageof 15

Showing results (41-50 of 143) with videos related to

Sort By:
Pageof 15
Small (Weinheim an Der Bergstrasse, Germany)|June 6, 2008
A multimodal targeting nanoparticle for selectively labeling T cellsJonathan Gunn, Herschel Wallen, Omid Veiseh, et al.
Cellular Immunology|May 19, 2018
Early Env-specific CTLs effectively suppress viral replication in SHIV controller macaquesJin Fan, Hua Liang, Tao Shen, et al.
Frontiers in Immunology|January 19, 2026
IL-7: a potential next-generation adjuvant for immune cell therapiesRichard S Hotchkiss, John F DiPersio, Cassian Yee, et al.
Cancer Research|March 1, 2005
Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptorJeffrey J Roszkowski, Gretchen E Lyons, W Martin Kast, et al.
Journal for Immunotherapy of Cancer|October 6, 2020
Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximabJamie S Lin, Daniel Y Wang, Omar Mamlouk, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2005
Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cellsVeronika Groh, Yongqing Q Li, Daniel Cioca, et al.
Research Square|December 23, 2024
BH3 Mimetics Augment Cytotoxic T Cell Killing of Acute Myeloid Leukemia via Mitochondrial Apoptotic MechanismCassian Yee, Kapil Saxena, Esther Ryu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2010
NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune diseaseNobuyoshi Hanaoka, Bana Jabri, Zhenpeng Dai, et al.
Biorxiv : the Preprint Server for Biology|July 27, 2021
Immunogenic SARS-CoV2 Epitopes Defined by Mass SpectrometryKe Pan, Yulun Chiu, Eric Huang, et al.
Nature Communications|May 23, 2019
CTL-mediated immunotherapy can suppress SHIV rebound in ART-free macaquesJin Fan, Hua Liang, Xiaolin Ji, et al.
Pageof 15